Veneto Tumour Registry, Azienda Zero, Padova, Italy
Veneto Tumour Registry, Azienda Zero, Padova, Italy.
Gut. 2022 Mar;71(3):561-567. doi: 10.1136/gutjnl-2020-322192. Epub 2021 Mar 31.
The risk of colorectal cancer (CRC) among subjects with a positive faecal immunochemical test (FIT) who do not undergo a colonoscopy is unknown. We estimated whether non-compliance with colonoscopy after a positive FIT is associated with increased CRC incidence and mortality.
The FIT-based CRC screening programme in the Veneto region (Italy) invited persons aged 50 to 69 years with a positive FIT (>20 µg Hb/g faeces) for diagnostic colonoscopy at an endoscopic referral centre. In this retrospective cohort study, we compared the 10-year cumulative CRC incidence and mortality among FIT positives who completed a diagnostic colonoscopy within the programme (compliers) and those who did not (non-compliers), using the Kaplan-Meier estimator and Cox-Aalen models.
Some 88 013 patients who were FIT positive complied with colonoscopy (males: 56.1%; aged 50-59 years: 49.1%) while 23 410 did not (males: 54.6%; aged 50-59 years: 44.9%).The 10-year cumulative incidence of CRC was 44.7 per 1000 (95% CI, 43.1 to 46.3) among colonoscopy compliers and 54.3 per 1000 (95% CI, 49.9 to 58.7) in non-compliers, while the cumulative mortality for CRC was 6.8 per 1000 (95% CI, 5.9 to 7.6) and 16.0 per 1000 (95% CI, 13.1 to 18.9), respectively. The risk of dying of CRC among non-compliers was 103% higher than among compliers (adjusted HR, 2.03; 95% CI, 1.68 to 2.44).
The excess risk of CRC death among those not completing colonoscopy after a positive faecal occult blood test should prompt screening programmes to adopt effective interventions to increase compliance in this high-risk population.
粪便免疫化学检测(FIT)阳性但未行结肠镜检查的患者罹患结直肠癌(CRC)的风险尚不清楚。我们评估了 FIT 阳性后不进行结肠镜检查是否与 CRC 发病率和死亡率增加相关。
意大利威尼托地区基于 FIT 的 CRC 筛查项目邀请了年龄在 50 至 69 岁之间、FIT 阳性(粪便血红蛋白>20μg/g)的人群到内镜转诊中心进行诊断性结肠镜检查。在这项回顾性队列研究中,我们使用 Kaplan-Meier 估计值和 Cox-Aalen 模型比较了在项目内完成诊断性结肠镜检查的 FIT 阳性者(依从者)和未完成者(不依从者)的 10 年 CRC 累计发病率和死亡率。
88013 名 FIT 阳性者接受了结肠镜检查(男性占 56.1%;年龄 50-59 岁者占 49.1%),23410 名 FIT 阳性者未接受结肠镜检查(男性占 54.6%;年龄 50-59 岁者占 44.9%)。结肠镜检查依从者的 10 年 CRC 累计发病率为 44.7/1000(95%CI,43.1 至 46.3),不依从者为 54.3/1000(95%CI,49.9 至 58.7),CRC 累计死亡率分别为 6.8/1000(95%CI,5.9 至 7.6)和 16.0/1000(95%CI,13.1 至 18.9)。不依从者 CRC 死亡风险比依从者高 103%(校正 HR,2.03;95%CI,1.68 至 2.44)。
粪便潜血试验阳性后不进行结肠镜检查的患者 CRC 死亡风险增加,这应促使筛查项目采取有效干预措施,提高高危人群的依从性。